Exclusive partnership ensures infrastructure readiness for world’s first consumer MEG centres, supporting MYndspan’s Crowdcube campaign and international rollout
MYndspan, the first company to offer clinical-grade MEG brain scanning to consumers, announced an exclusive partnership with IMEDCO, the global leader in magnetically shielded room (MSR) infrastructure. IMEDCO will be the sole supplier of MSRs for all future MYndspan scanning sites.
This collaboration ensures MYndspan can scale its flagship MEG brain health centres with world-class shielding systems, supporting expansion across the UK and internationally. The partnership also underpins MYndspan’s active Crowdcube raise and ensures the company is infrastructure-ready for rapid growth.
Secure Your Spot in the Future of Brain Health
Early investors will receive priority access to MYndspan’s brain health scanning service, launching at our flagship London site later this year. With limited scan capacity and growing media attention—from The Guardian, Stylist Magazine, and ITV News—demand is expected to exceed availability.
Health Technology Insights: Johnson & Johnson Reveals Game-Changing Bladder Cancer Data at AUA
Invest now on Crowdcube to reserve your place and be among the first to experience the world’s most advanced brain scan.
Invest in MYndspan on Crowdcube.
Laying the Foundation for Scalable Precision
MYndspan provides real-time brain scans that deliver actionable insights, including Functional Brain Age and Brain Stability Index, through a 10-minute MEG scan and a 45-minute in-person appointment. MEG is the most precise method for measuring brain function but requires high-performance magnetic shielding to operate safely and accurately.
“IMEDCO’s magnetically shielded rooms are the best performing in the world,” said Caitlin Baltzer, Co-Founder and CEO of MYndspan. “Partnering with them gives us the turnkey infrastructure we need to scale MEG scanning from our flagship site in London to clinics and wellness centres around the world. They’re not just a supplier; they’re enabling our mission.”
Health Technology Insights: ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology
IMEDCO will serve as the exclusive MSR provider for MYndspan, outfitting all future sites with their market-leading shielding systems. With over 10.000 RF cages installed globally and a world-record in shielding performance, IMEDCO’s engineering expertise and international presence make them a vital partner in expanding access to MEG worldwide
“We are proud to support MYndspan on their journey to bring MEG out of the research lab and into widespread clinical use, said Jakob Selzer, CEO of IMEDCO. “We firmly believe that this groundbreaking brain scan technology will soon open up new diagnostic possibilities for people around the world.”
Bringing Advanced Neurotechnology to the Public
Backed by partners including MEGIN, BIOS Health, EMOTIV, and now IMEDCO, MYndspan’s service offers clinical-grade MEG scans in a consumer setting for the first time. These scans evaluate real-time brain activity and help detect early signs of cognitive decline, injury, or disrupted connectivity, often before symptoms appear or structural changes are visible on MRI.
MEG has long been confined to research and hospital settings due to its complexity and cost. MYndspan and IMEDCO are removing that barrier, combining cutting-edge science with scalable infrastructure.
Be Part of What’s Next in Brain Health
Neurological conditions are now the world’s leading cause of poor health. With up to 45% of dementia cases considered preventable through early intervention, consumer-accessible brain scanning is becoming an essential component of preventive healthcare.
Health Technology Insights: AbsoluteCare Expands its Partnership with CareSource
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
